Recruitment status changed
Before: Not yet recruiting. After: Recruiting.
Study sponsor: Akebia Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: Not yet recruiting. After: Recruiting.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Incidence of adverse events (AEs) to evaluate the safety of ADX-097. After: Measure: Number of participants reporting treatment emergent adverse events (TEAEs).
Before: Actual. After: Estimated.
Before: 0 participants (actual). After: 30 participants (planned).
Before: Jun 2026. After: Feb 2028.
Before: Withdrawn. After: Not yet recruiting.